Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale

• Main Authors: R. M. Paltuev (Author), O. A. Volynshchikova (Author), Sh. R. Abdullaeva (Author), S. N. Aleksakhina (Author), A. S. Artemyeva (Author), E. A. Baychorov (Author), S. Yu. Bakharev (Author), Yu. A. Belaya (Author), A. A. Bozhok (Author), V. A. Vasin (Author), V. I. Vladimirov (Author), A. Yu. Vorontsov (Author), E. A. Gaysina (Author), A. A. Gofman (Author), V. N. Dmitriev (Author), E. N. Imyanitov (Author), V. V. Klimenko (Author), A. V. Komyakhov (Author), M. M. Konstantinova (Author), M. V. Kopp (Author), A. G. Kudaybergenova (Author), I. A. Lalak (Author), D. L. Matevosyan (Author), N. M. Mudzhiri (Author), O. V. Poltareva (Author), O. I. Sevryukova (Author), V. F. Semiglazov (Author), T. Yu. Semiglazova (Author), M. M. Urezkova (Author), A. S. Chichkanova (Author), L. A. Churilova (Author), M. V. Shomova (Author)
• Format: Book
• Published: ABV-press, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Individual molecular characteristics of a tumor can serve as a basis for a tailored approach to therapy, prediction of the disease course and outcome, and timely treatment correction in cancer patients. Tumor genomic profiling allows for a more precise tumor assessment in an individual m...